B. Maron

Cardiology and Cardiovascular Medicine · 2000–2018

A researcher in the Science corpus: 32 papers; trusts 7 researchers and is trusted by 27 researchers here, as inferred from the citation graph.

Subfields

• Cardiology and Cardiovascular Medicine — 167 citations into it; #18 of 906 by trust here, #15 by citations

Whom B. Maron trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. M. Maron
2. Iacopo Olivotto
3. P. Spirito
4. F. Cecchi
5. Mark S. Link
6. B. J. Gersh
7. A. Zenovich
8. C. Semsarian
9. Steve R. Ommen
10. S. Betocchi

Who trusts B. Maron overall

1. B. J. Gersh
2. P. Spirito
3. Steve R. Ommen
4. M. Maron
5. Iacopo Olivotto
6. C. Semsarian
7. N. K. Lakdawala
8. R. Bonow
9. J. Dearani
10. Mark S. Link

Papers from B. Maron's perspective

Ordered by how strongly the researchers B. Maron trusts endorse each paper. Same corpus, a different order for every researcher.

1. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. (Journal of the American College of Cardiology)
2. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. (JACC Cardiovascular Imaging)
3. Assessment of Myocardial Fibrosis with Cardiac Magnetic Resonance (Journal of the American College of Cardiology)
4. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. (Journal of the American College of Cardiology)
5. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice… (Journal of Thoracic and Cardiovascular Surgery)
6. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors
7. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond (Statistics in Medicine)
8. Nonparametric Estimation from Incomplete Observations
9. Does sports activity enhance the risk of sudden death in adolescents and young adults? (Journal of the American College of Cardiology)
10. Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy (Circulation)

Their papers

• Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly (2002) — 388 citations
• Clinical Course and Management of Hypertrophic Cardiomyopathy (2018) — 737 citations
• New perspectives on the prevalence of hypertrophic cardiomyopathy. (2015) — 1,241 citations
• Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy (2014) — 917 citations
• Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. (2014) — 632 citations
• Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy. (2011) — 101 citations
• 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2011) — 1,435 citations
• 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Soci (2011) — 1,097 citations
• 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2011) — 937 citations
• 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) — 848 citations
• Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. (2010) — 880 citations
• Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980–2006 (2009) — 1,580 citations
• Recommendations for interpretation of 12-lead electrocardiogram in the athlete. (2009) — 792 citations
• Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. (2007) — 715 citations
• Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. (2007) — 940 citations
• Recommendations and Considerations Related to Preparticipation Screening for Cardiovascular Abnormalities in Competitive Athletes: 2007 Update: A Scientific Statement From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism Endorsed by the American College of Cardi (2007) — 1,050 citations
• The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. (2006) — 763 citations
• Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction (2006) — 924 citations
• Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy (2006) — 637 citations
• Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd (2006) — 3,055 citations